| 000 | 01720 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516101155.0 | ||
| 264 | 0 | _c20121119 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-012-1503-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorn, Julia | |
| 245 | 0 | 0 |
_aTreatment option of bendamustine in combination with rituximab in elderly and frail patients with aggressive B-non-Hodgkin lymphoma: rational, efficacy, and tolerance. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cOct 2012 |
||
| 300 |
_a1579-86 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aBendamustine Hydrochloride |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFrail Elderly |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xpathology |
| 650 | 0 | 4 |
_aNitrogen Mustard Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKleber, Martina | |
| 700 | 1 | _aHieke, Stefanie | |
| 700 | 1 | _aSchmitt-Gräff, Annette | |
| 700 | 1 | _aWäsch, Ralph | |
| 700 | 1 | _aEngelhardt, Monika | |
| 773 | 0 |
_tAnnals of hematology _gvol. 91 _gno. 10 _gp. 1579-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-012-1503-5 _zAvailable from publisher's website |
| 999 |
_c21911458 _d21911458 |
||